Gerald So
Neurology with Special Qualifications in Child Neurology · Plano, TXNPI 1235294695
Payments from drug & device makers
Across 247 payments — averaging $19.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$383
- UCB, Inc.$367
- Livanova USA, Inc.$326
- Neurelis, Inc.$306
- Sunovion Pharmaceuticals Inc.$304
- Eisai Inc.$270
- plus $3K from 41 others
What the payments were for
- Food & beverage$4,82799%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$4,861 in reported general payments places this provider in the 65th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MysolinePrimidone | 13 | $102,225 |
| Felbamate | 42 | $31,518 |
| VimpatLacosamide | 12 | $24,710 |
| XcopriCenobamate | 17 | $24,309 |
| KeppraLevetiracetam | 12 | $11,580 |
| Aripiprazole | 21 | $7,810 |
| Depakote SprinkleDivalproex Sodium | 12 | $7,279 |
| LevocarnitineLevocarnitine (With Sugar) | 12 | $1,046 |
| Lamotrigine | 16 | $607 |
| Paroxetine Hcl | 14 | $216 |
| Trazodone Hcl | 20 | $142 |
| Fluoxetine Hcl | 22 | $126 |
| Clonidine Hcl | 14 | $68 |
| Sertraline Hcl | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| UCB, Inc.Vimpat | $367 | $24,71012 claims |
| SK Life Science, Inc.Xcopri | $124 | $24,30917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
Other neurology with special qualifications in child neurology in Plano
- Robert ChudnowPlano$13K
- Safiullah ShareefPlano$11K
- Andrew HurdPlano$10K
- Mohsin MaqboolPlano$8K
- Lina ShahPlano$6K
- Huda ZoghbiHouston$8.3M
- Roy EltermanDallas$5.9M
- Diana CastroDenton$2.8M
- Jerry TomasovicSan Antonio$1.5M
- Mary Kay KoenigHouston$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.